Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression

International Journal of Geriatric Psychiatry

Volumn 22, Issue 5, 2007, Pages 468-474

  Janssen, Joost ^a,b,e   Hulshoff Pol, Hilleke E ^a   Schnack, Hugo G ^a   Kok, Rob M ^b   Lampe, Indrag K ^c   de Leeuw, Frank Erik ^c   Kahn, Rene S ^a   Heeren, Thea J ^a,d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Department of Old Age Psychiatry ^*  (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Symfora Group   (Netherlands)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Hippocampus; Late life depression; MRI; Outcome; Response; Treatment; White matter lesions

Indexed keywords

ANTIDEPRESSANT AGENT; HALOPERIDOL; NORTRIPTYLINE; OXAZEPAM; RISPERIDONE; TEMAZEPAM; VENLAFAXINE;

ADULT; ARTICLE; BRAIN DAMAGE; BRAIN SCINTISCANNING; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFOUNDING VARIABLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG RESPONSE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MONOTHERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; ORBITAL CORTEX; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; SHORT COURSE THERAPY; TREATMENT DURATION; WHITE MATTER;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOARAIOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; NORTRIPTYLINE;

EID: 34249748764     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.1790     Document Type: Article

References (38)

1. American Psychiatric Association. 1994. Diagnostic & Statistical Manual of Mental Disorders (DSM-IV), 4th edition. American Psychiatric Association, Washington, DC.
2. Baldwin R, Jeffries S, Jackson A, et al. 2004. Treatment response in late-onset depression: relationship to neuropsychological, neuroradiological and vascular risk factors. Psychol Med 34: 125-136.
3. Baldwin RC, Walker S, Simpson SW, et al. 2000. The prognostic significance of abnormalities seen on magnetic resonance imaging in late life depression: clinical outcome, mortality and progression to dementia at three years. Int J Geriatr Psychiatry 15: 1097-1104.
4. Bartko JJ, Carpenter WT. 1976. On the methods and theory of reliability. J Nerv Ment Dis 163: 307-317.
5. Burvill PW, Mowry B, Hall WD. 1990. Quantification of physical illness in psychiatric research in the elderly. Int J Geriatr Psychiatry 5: 161-170.
6. Chen PS, McQuoid DR, Payne ME, Steffens DC. 2006. White matter and subcortical gray matter lesion volume changes and late-life depression outcome: a 4-year magnetic resonance imaging study. Int Psychogeriatr 10: 1-12.
7. Coffey CE, Wilkinson WE, Weiner RD, et al. 1993. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry 50: 7-16.
8. Folstein MF, Folstein SE, McHugh PR. 1975. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198.
9. Frodl T, Meisenzahl EM, Zetzsche T, et al. 2002. Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159: 1112-1118.
10. Hickie I, Scott E, Mitchell P, et al. 1995. Subcortical hyper-intensities on magnetic resonance imaging: clinical correlates and prognostic significance in patients with severe depression. Biol Psychiatry 37: 151-160.
11. Hickie I, Scott E, Wilhelm K, Brodaty H. 1997. Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression - a longitudinal evaluation. Biol Psychiatry 42: 367-374.
12. Hiller W, Zaudig M, Mombour W. 1990. Development of diagnostic checklists for use in routine clinical care. A guideline designed to assess DSM-III-R diagnoses. Arch Gen Psychiatry 47: 782-784.
13. Hsieh MH, McQuoid DR, Levy RM, et al. 2002. Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry 17: 519-525.
14. Janssen J, Hulshoff Pol HE, Lampe IK, et al. 2004. Hippocampal changes and white matter lesions in early-onset depression. Biol Psychiatry 56: 825-831.
15. Krishnan KR, Goli V, Ellinwood EH, France RD, et al. 1988. Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry 23: 519-522.
16. Krishnan KR, Hays JC, George LK, Blazer DG. 1998. Six-month outcomes for MRI-related vascular depression. Depress Anxiety 8: 142-146.
17. Kumar A, Bilker W, Jin Z, Udupa J. 2000. Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression. Neuropsychopharmacology 22: 264-274.
18. Lai T, Payne ME, Byrum CE, et al. 2000. Reduction of orbital frontal cortex volume in geriatric depression. Biol Psychiatry 48: 971-975.
19. Lavretsky H, Lesser IM, Wohl M, et al. 1999. Clinical and neuroradiologic features associated with chronicity in late-life depression. Am J Geriatr Psychiatry 7: 309-316.
20. MacQueen GM, Campbell S, McEwen BS, et al. 2003. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 100: 1387-1392.
21. Mahoney FI, Barthel DW. 1965. Functional Evaluation: the Barthel Index. Md State Med J 14: 61-65.
22. Montgomery SA, Asberg M. 1979. A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
23. O'Brien J, Ames D, Chiu E, et al. 1998. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study. BMJ 317: 982-984.
24. O'Brien J, Desmond P, Ames D, et al. 1996. A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. Br J Psychiatry 168: 477-485.
25. O'Brien JT, Lloyd A, McKeith I, et al. 2004. A longitudinal study of hippocampal volume, cortisol levels, and cognition in older depressed subjects. Am J Psychiatry 161: 2081-2090.
26. Salloway S, Boyle PA, Correia S, et al. 2002. The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry 10: 107-111.
27. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM. 1998. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiatry 172:527-532.
28. Sheline YI, Sanghavi M, Mintun MA, Gado MH. 1999. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 19: 5034-5043.
29. Simpson S, Baldwin RC, Jackson A, Burns AS. 1998. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med 28: 1015-1026.
30. Simpson SW, Baldwin RC, Burns A, Jackson A. 2001. Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment and response to treatment. Int J Geriatr Psychiatry 16: 469-476.
31. Simpson SW, Jackson A, Baldwin RC, Burns A. 1997. 1997 IPA/Bayer Research Awards in Psychogeriatrics. Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment. Int Psychogeriatr 9: 257-275.
32. Steffens DC, Byrum CE, McQquoid DR, et al. 2000. Hippocampal volume in geriatric depression. Biol Psychiatry 48: 301-309.
33. Steffens DC, Helms MJ, Krishnan KR, Burke GL. 1999. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 30: 2159-2166.
34. Talairach J, Tournoux P. 1988. Co-planar Stereotaxic Atlas of the Human Brain. Thieme: NewYork.
35. Taylor WD, MacFall JR, Payne ME. 2005. Greater MRI lesion volumes in elderly depressed subjects than in control subjects. Psychiatry Res 139: 1-7.
36. Taylor WD, Steffens DC, MacFall JR, et al. 2003. White matter hyperintensity progression and late-life depression outcomes. Arch Gen Psychiatry 60: 1090-1096.
37. Vythilingam M, Vermetten E, Anderson GM, et al. 2004. Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry 56: 101-112.
38. Young RC, Kalayam B, Nambudiri DE, et al. 1999. Brain morphology and response to nortriptyline in geriatric depression. Am J Geriatr Psychiatry 7: 147-150.